Condor

Henry Schein (Nasdaq:HSIC) announced today that it completed its previously announced acquisition of Condor Dental Research Company.

Melville, New York-based Henry Schein announced the acquisition, for which financial terms were not disclosed, a month ago on June 7. It acquired Condor from MCCB Holding Sarl and expects the transaction to be neutral to its 2022 diluted earnings per share and accretive thereafter.

The company has served the Swiss dental implant market through Camlog Biotechnologies GmbH, a member of the Global Oral Reconstruction Group (a Basel, Switzerland-based division of the company). Through its acquisition of Condor Dental, the company aims to expand its entry into the Swiss market for dental distribution.

Condor Dental, which brings in most of its revenues from dental consumable merchandise, reported sales of approximately $18 million in 2021. Now that the acquisition has closed, the company will join Henry Schein’s international di…

Henry Schein (Nasdaq:HSIC) announced today that it signed a definitive agreement to acquire Condor Dental Research Company.

Vouvry, Switzerland-based Condor Dental, a privately held dental distribution company, serves dental general practitioners, specialists and laboratories.

Melville, New York-based Henry Schein has served the Swiss dental implant market through Camlog Biotechnologies GmbH, a member of the Global Oral Reconstruction Group (a Basel, Switzerland-based division of the company). The company said in a news release that adding Condor Dental will expand its entry into the Swiss market for dental distribution.

Condor Dental brought in sales of approximately $18 million in 2021, with the majority coming from dental consumable merchandise. The company will join Henry Schein’s international distribution group once the transaction closes and the business will continue to operate under COO Yves Mailliard’s lead.

“We look forward …